Other ·Emerging evidence ·Reviewed May 2026
Direct precursor to NAD+, the critical coenzyme that declines with age. At the forefront of longevity research for cellular rejuvenation and anti-aging.
The bottom line
Evidence rating emerging. Most-documented uses: nad+ restoration, anti-aging, energy metabolism. 18 sources indexed (2021–2026), with 6 interaction records on file.
Core mechanism
Converted to NAD+ via nicotinamide mononucleotide adenylyltransferase (NMNAT). NAD+ is essential for sirtuins (SIRT1-7, longevity genes), PARPs (DNA repair), CD38 (immune regulation), and hundreds of metabolic reactions. Plasma levels decline approximately 60% over lifespan, but varies greatly by tissue: brain only 10-25%, CSF ~14%.1,3
Take in the morning on empty stomach; sublingual delivery avoids first-pass metabolism9,1
Dosing protocol
Raises whole blood NAD+ by 20-60% in trials. Mechanism is established; longevity endpoints in humans are not.9
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Sublingual NMN / Capsules.
Assumes 250-1,000 mg/day. Vendor basis: iHerb, Life Extension-style healthy-aging brands, Amazon marketplace, and specialty NMN vendors; high-dose and enteric formats are premium. Updated 2026-05-28.
How much you'd eat to match a supplemental dose.
A practical whole-food equivalent for NMN does not exist.
What to test, the optimal window inside the conventional range, and how long a response takes.
Nicotinamide mononucleotide (250 to 500 mg per day) raises whole blood NAD+ by 20 to 60 percent in 8- to 12-week RCTs.1,8
Specialty labs (Jinfiniti, ChromaDex) offer dried blood spot NAD+ assays. Standardize collection time and avoid same-day intense exercise.
Where this appears in the symptom-to-supplement map, ranked by relevance.
NMN raises whole blood NAD+ by 20 to 60 percent; downstream longevity endpoints in humans are not yet established.16,11
Mechanism is established; clinical lifespan endpoints are not.
NMN is an NAD+ precursor, and because low NAD+ has been proposed in fatigue states it may theoretically support mitochondrial energy production.13
Human ME/CFS evidence is preliminary; treat claims cautiously, confirm with your clinician, and view as supportive only.
Evidence-based stacks that include it, with the exact dose and timing each one uses.
NAD+ precursor studied in early human trials for NAD+ and selected metabolic or muscle-function markers; clinical outcome benefits are not established.15,1
NMN is a direct NAD+ precursor that feeds the salvage pathway and has been shown in early human trials to raise blood NAD+ levels. Effects on aging biomarkers and clinical outcomes are still preliminary.
NMN is a precursor to NAD+, the coenzyme that carries electrons into Complex I and participates in many redox reactions across energy metabolism. Early human trials suggest oral dosing can raise NAD+ markers, but durable functional benefits in healthy adults remain unproven and the evidence base is still emerging.
NMN supports NAD+-pathway markers, while resveratrol has sirtuin-related preclinical research; direct human evidence for the combination is absent.
Recommendation: Present as an exploratory pairing only. Do not claim proven longevity, healthspan, DNA-repair, or clinical outcome benefits from the combination.
Both are NAD+ precursors through different pathways. Taking both may be redundant and could lead to excessive NAD+ precursor supplementation.
Recommendation: Choose one NAD+ precursor strategy. NMN is generally preferred for direct NAD+ boosting via the salvage pathway.
NMN boosts NAD+ for mitochondrial enzymes; CoQ10 supports the electron transport chain. Comprehensive mitochondrial support for anti-aging.
Recommendation: Combine for mitochondrial anti-aging strategy. NMN fuels NAD+-dependent enzymes; CoQ10 maintains ETC efficiency.
NMN boosts NAD+ for mitochondrial enzymes; CoQ10 supports the electron transport chain. Comprehensive mitochondrial support for anti-aging.
Recommendation: Combine for mitochondrial anti-aging strategy. NMN fuels NAD+-dependent enzymes; CoQ10 maintains ETC efficiency.
NMN raises NAD+ substrate; apigenin inhibits CD38, the enzyme that consumes NAD+. Combined effect on whole blood NAD+ may be additive.
Recommendation: Combine for NAD+ optimization in longevity-focused stacks. Track NAD+ via specialty assays (Jinfiniti, ChromaDex) at baseline and 8 weeks.
PQQ and NMN act on convergent mitochondrial and NAD-related pathways, supporting mitochondrial biogenesis and cellular energy metabolism through complementary routes.
Recommendation: Reasonable to take together for energy and mitochondrial support. No timing separation required.
Numbered references. Citations throughout the page link here.
Zhang M, Chen Y, Jiang N et al.. Effects of Nicotinamide Mononucleotide Supplementation on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2026
Noh H, Sen Gupta S, Seshadri S et al.. NMN supplementation as a strategy to improve oocyte quality: a systematic review and transcriptomic analysis. Journal of assisted reproduction and genetics. 2026
Zhang J, Poon ET, Wong SH. Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials. Critical reviews in food science and nutrition. 2025
Wang JP, Wang L, Wang T et al.. Effects of Nicotinamide Mononucleotide Supplementation on Muscle and Liver Functions Among the Middle-aged and Elderly: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Current pharmaceutical biotechnology. 2025
Prokopidis K, Moriarty F, Bahat G et al.. The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis. Journal of cachexia, sarcopenia and muscle. 2025
Wen J, Syed B, Kim S et al.. Improved Physical Performance Parameters in Patients Taking Nicotinamide Mononucleotide (NMN): A Systematic Review of Randomized Control Trials. Cureus. 2024
Chen F, Zhou D, Kong AP et al.. Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials. Current diabetes reports. 2024
12-week NMN intake significantly increased blood NAD+, maintained walking speed, and improved sleep quality (PSQI daytime dysfunction and global scores).
Clinical efficacy by blood NAD concentration and physical performance reached highest at 600 mg daily oral intake; NMN was safe and well tolerated.
Oral NMN administration is safe with no adverse events and efficiently increases blood NAD+ levels in healthy subjects.
Huang H. A Multicentre, Randomised, Double Blind, Parallel Design, Placebo Controlled Study to Evaluate the Efficacy and Safety of Uthever (NMN Supplement), an Orally Administered Supplementation in Middle Aged and Older Adults. Frontiers in aging. 2022
A dozen human clinical trials show NMN safely increases blood NAD levels up to 900 mg daily; a significant effect on NAD elevation confirmed by meta-analysis.
NAD+ levels deplete ~60% over lifespan; NMN supplementation can slow aging by elevating NAD+ but theoretical cancer concerns exist with NAD+ raising.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack